Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments
Clinical trial NCT04454437 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04454437
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2021-08-06
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.